DE69223939D1 - Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren - Google Patents

Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren

Info

Publication number
DE69223939D1
DE69223939D1 DE69223939T DE69223939T DE69223939D1 DE 69223939 D1 DE69223939 D1 DE 69223939D1 DE 69223939 T DE69223939 T DE 69223939T DE 69223939 T DE69223939 T DE 69223939T DE 69223939 D1 DE69223939 D1 DE 69223939D1
Authority
DE
Germany
Prior art keywords
cpv
protein
related viruses
vaccine against
fplv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69223939T
Other languages
English (en)
Other versions
DE69223939T2 (de
Inventor
Valdes Elena Cortes
Olmo Carmen Vela
Alvarez Jose Casal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inmunologia y Genetica Aplicada SA
Original Assignee
Inmunologia y Genetica Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inmunologia y Genetica Aplicada SA filed Critical Inmunologia y Genetica Aplicada SA
Publication of DE69223939D1 publication Critical patent/DE69223939D1/de
Application granted granted Critical
Publication of DE69223939T2 publication Critical patent/DE69223939T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69223939T 1991-03-26 1992-03-26 Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren Expired - Lifetime DE69223939T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9100844A ES2026826A6 (es) 1991-03-26 1991-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.
PCT/ES1992/000031 WO1992017205A1 (es) 1991-03-26 1992-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados

Publications (2)

Publication Number Publication Date
DE69223939D1 true DE69223939D1 (de) 1998-02-12
DE69223939T2 DE69223939T2 (de) 1998-07-09

Family

ID=8271929

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69223939T Expired - Lifetime DE69223939T2 (de) 1991-03-26 1992-03-26 Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren

Country Status (8)

Country Link
US (1) US5882652A (de)
EP (1) EP0554414B1 (de)
AT (1) ATE161729T1 (de)
AU (1) AU1585092A (de)
DE (1) DE69223939T2 (de)
DK (1) DK0554414T3 (de)
ES (1) ES2026826A6 (de)
WO (1) WO1992017205A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2113572A1 (en) * 1991-07-17 1993-02-04 Peter J. Walker Improved vaccine
CA2132742C (en) * 1993-01-23 2000-04-18 Carmen Vela Olmo Synthetic peptides and vaccines against parvovirus
ES2065254B1 (es) * 1993-01-23 1995-07-16 Inmunologia & Genetica Aplic Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
US5885585A (en) * 1994-11-08 1999-03-23 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US5814510A (en) * 1994-11-08 1998-09-29 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
EP0914440B1 (de) * 1996-04-19 2007-01-10 Merial Ltd. Impfung mit nukleinsäuren gegen parvovirus infektionen
EP0959893A4 (de) 1996-12-10 2004-11-10 Sloan Kettering Institutefor C Stimulierung einer immunantwort auf ein differentiationsantigen, das durch ein verändertes antigen stimuliert wird
US7556805B2 (en) 1996-12-10 2009-07-07 Sloan-Kettering Inststute for Cancer Research and The Animal Medical Center Compositions for treatment of melanoma and method of using same
CA2223029A1 (en) 1997-02-12 1998-08-12 Akzo Nobel Nv Canine parvovirus dna vaccines
EP0863151A1 (de) * 1997-02-12 1998-09-09 Akzo Nobel N.V. Hundeparvovirus DNA Impfstoffe
US8021666B2 (en) 1997-02-18 2011-09-20 Sloan-Kettering Institute For Cancer Research Method and compositions for stimulation of an immune response to CD20 using a xenogeneic CD20 antigen
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
US6759237B1 (en) * 1998-11-05 2004-07-06 The Trustees Of The University Of Pennsylvania Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
CA2348382C (en) * 1998-11-10 2013-09-17 The University Of North Carolina At Chapel Hill Chimeric parvovirus vectors and methods of making and administering the same
JP2003526377A (ja) * 2000-03-14 2003-09-09 ニユーロロジクス・インコーポレーテツド キメラキャプシドベクターの製造
CN101124328A (zh) * 2004-12-15 2008-02-13 北卡罗来纳查佩尔山大学 嵌合载体
EP1981548A4 (de) * 2006-01-20 2010-03-24 Univ North Carolina Verstärkte produktion von infektiösen parvovirus-vektoren in insektenzellen
NZ599585A (en) * 2007-06-14 2013-12-20 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
EP2391713A1 (de) * 2009-01-30 2011-12-07 The Board Of Regents For Oklahoma State University Immunogene zusammensetzungen, impfstoffe und diagnostika auf der grundlage von in nordamerikanischen hunden verbreiteten hundestaupeviren
WO2010093784A2 (en) 2009-02-11 2010-08-19 The University Of North Carolina At Chapel Hill Modified virus vectors and methods of making and using the same
CA2777692A1 (en) 2009-10-14 2011-04-21 Sanjay Kapil Isolation of a virus related to canine parvovirus-2 from a raccoon
ES2683695T3 (es) 2010-01-12 2018-09-27 The University Of North Carolina At Chapel Hill Repeticiones terminales invertidas restrictivas para vectores virales
EP2673289B1 (de) 2011-02-10 2023-05-03 The University of North Carolina At Chapel Hill Virale vektoren mit modifizierten transduktionsprofilen sowie verfahren zu ihrer herstellung und verwendung
PL2900686T3 (pl) 2012-09-28 2021-01-25 The University Of North Carolina At Chapel Hill Wektory aav ukierunkowane na oligodendrocyty
IL298049B2 (en) 2013-03-15 2023-10-01 Univ North Carolina Chapel Hill Methods and compounds for ligation of paired AAV glycan vectors
EP2970966A4 (de) 2013-03-15 2016-10-26 Univ North Carolina Synthetische adenoassoziierte virusinvertierte endwiederholungssequenzen
CN104388394B (zh) * 2014-10-22 2017-03-15 中国农业科学院特产研究所 水貂细小病毒弱毒疫苗株及其在制备水貂细小病毒弱毒疫苗中的用途
RU2727015C2 (ru) 2014-11-21 2020-07-17 Дзе Юниверсити Оф Норт Каролина Эт Чепел Хилл Векторы aav, нацеленные на центральную нервную систему
CA2972807C (en) 2015-01-14 2024-01-16 The University Of North Carolina At Chapel Hill Methods and compositions for targeted gene transfer
KR102554850B1 (ko) 2015-02-06 2023-07-13 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 최적화된 인간 응고 인자 viii 유전자 발현 카세트 및 그의 용도
SG10202107733QA (en) 2015-09-28 2021-09-29 Univ North Carolina Chapel Hill Methods and compositions for antibody-evading virus vectors
WO2017190031A1 (en) 2016-04-28 2017-11-02 Indiana University Research And Technology Corporation Methods and compositions for resolving components of a virus preparation
CN117801075A (zh) 2017-03-15 2024-04-02 北卡罗来纳-查佩尔山大学 多倍体腺相关病毒载体及其制备和使用方法
EP3685168A1 (de) 2017-09-20 2020-07-29 The Trustees Of Indiana University Verfahren zur auflösung von lipoproteinen mit massenspektrometrie
CN107827958B (zh) * 2017-11-11 2020-08-25 中牧实业股份有限公司 犬细小病毒合成肽疫苗及其制备方法和应用
EP3738137A1 (de) 2018-01-12 2020-11-18 The Trustees of Indiana University Konstruktion einer elektrostatischen linearen ionenfalle für massenspektrometrie mit ladungsdetektion
EP3773743A1 (de) 2018-04-03 2021-02-17 Stridebio, Inc. Virusvektoren gegen ophthalmisches gewebe
KR20210006357A (ko) 2018-04-03 2021-01-18 스트라이드바이오 인코포레이티드 항체-회피 바이러스 벡터
KR20210007963A (ko) 2018-04-03 2021-01-20 스트라이드바이오 인코포레이티드 항체-회피 바이러스 벡터
CA3100840A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Apparatus and method for capturing ions in an electrostatic linear ion trap
WO2019236143A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Apparatus and method for calibrating or resetting a charge detector
JP7306727B2 (ja) 2018-06-04 2023-07-11 ザ・トラスティーズ・オブ・インディアナ・ユニバーシティー リアル・タイム分析および信号最適化による電荷検出質量分光分析法
EP3803953A1 (de) 2018-06-04 2021-04-14 The Trustees of Indiana University Ionenfallenanordnung für ladungsdetektionsmassenspektrometrie mit hohem durchsatz
WO2019236139A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Interface for transporting ions from an atmospheric pressure environment to a low pressure environment
JP7285023B2 (ja) 2018-11-20 2023-06-01 ザ・トラスティーズ・オブ・インディアナ・ユニバーシティー 単一粒子質量分光分析のためのオービトラップ
CA3118567A1 (en) 2018-12-03 2020-06-11 The Trustees Of Indiana University Apparatus and method for simultaneously analyzing multiple ions with an electrostatic linear ion trap
MX2021011468A (es) 2019-03-21 2021-12-15 Vectores de virus adenoasociados recombinantes.
WO2020219527A1 (en) 2019-04-23 2020-10-29 The Trustees Of Indiana University Identification of sample subspecies based on particle charge behavior under structural change-inducing sample conditions
EP4169535A1 (de) 2019-04-26 2023-04-26 The University of North Carolina at Chapel Hill Verfahren und zusammensetzungen für dualen glycanbindenden aav2,5-vektor
US20230392163A1 (en) 2019-10-17 2023-12-07 Ginkgo Bioworks Inc. Adeno-associated viral vectors for treatment of niemann-pick disease type c
EP4010356A4 (de) 2020-10-28 2023-01-04 The University of North Carolina at Chapel Hill Verfahren und zusammensetzungen für dualen glycanbindenden aav2.5-vektor
WO2022093769A1 (en) 2020-10-28 2022-05-05 The University Of North Carolina At Chapel Hill Methods and compositions for dual glycan binding aav2.5 vector
CN112553168B (zh) * 2020-12-23 2022-03-08 江苏省农业科学院 分泌抗猫细小病毒vp2蛋白单克隆抗体的杂交瘤细胞3a6株及其应用
TW202242124A (zh) 2021-01-14 2022-11-01 美商史崔德生物公司 靶向ｔ細胞之ａａｖ載體
JP2024515626A (ja) 2021-04-16 2024-04-10 アスクレピオス バイオファーマシューティカル， インコーポレイテッド 血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドａａｖビリオン
WO2023150687A1 (en) 2022-02-04 2023-08-10 Ginkgo Bioworks, Inc. Recombinant adeno-associated virus vectors, and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
WO1988002026A1 (en) * 1986-09-08 1988-03-24 Applied Biotechnology, Inc. Empty viral capsid vaccines
US4870023A (en) * 1987-03-16 1989-09-26 American Biogenetic Sciences, Inc. Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine
JP2755817B2 (ja) * 1988-11-14 1998-05-25 アメリカ合衆国 パルボウイルスキャプシド
CA2132742C (en) * 1993-01-23 2000-04-18 Carmen Vela Olmo Synthetic peptides and vaccines against parvovirus

Also Published As

Publication number Publication date
ES2026826A6 (es) 1992-05-01
DK0554414T3 (da) 1998-09-07
US5882652A (en) 1999-03-16
EP0554414B1 (de) 1998-01-07
ATE161729T1 (de) 1998-01-15
WO1992017205A1 (es) 1992-10-15
EP0554414A1 (de) 1993-08-11
DE69223939T2 (de) 1998-07-09
AU1585092A (en) 1992-11-02

Similar Documents

Publication Publication Date Title
DE69223939T2 (de) Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren
DE69222840T2 (de) Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus
KR920703831A (ko) 백신(vaccines)
JP6346143B2 (ja) 組換え弱毒化パルボウイルス
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
NO871313L (no) Fremgangsmaate for fremstilling av virusvaksine.
Xu et al. Baculovirus virions displaying infectious bursal disease virus VP2 protein protect chickens against infectious bursal disease virus infection
RU2001101426A (ru) Аттенуированные вирусы с минус-цепью с измененной антагонистической в отношении интерферона активностью для применения в качестве вакцин и фармацевтических веществ
DE69536138D1 (de) Rekombinantes Herpesvirus aus Truthähnen und seine Verwendungen
Thomas et al. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus
RU2012119494A (ru) Выделение вируса, родственного парвовирусу-2 собак, от енота
JP2021501757A (ja) 狂犬病ウイルスワクチン
Fahey et al. A recombinant subunit vaccine that protects progeny chickens from infectious bursal disease
JP2009544303A5 (de)
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
Mebatsion Introduction to Veterinary Vaccines
Vakharia Development of recombinant vaccines against infectious bursal disease
CA2366056A1 (en) Non-spreading pestivirus
Sheppard Viral vectors for veterinary vaccines
CA2198743A1 (en) Feline infectious peritonitis vaccine
ES2650622T3 (es) Vacunas que contienen variantes genéticas de parvovirus canino
CA2351010A1 (en) A broad spectrum infectious bursal disease virus vaccine
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
Pastoret et al. Regulatory considerations for emergency use of vaccines in the European Union
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 554414

Country of ref document: EP